• Targeting c-Myc with 10074-G5: Strategic Advances in Oncolog

  2026-04-20

  This thought-leadership article explores the transformative role of 10074-G5, a benchmark c-Myc inhibitor, in advancing translational cancer research. By dissecting the mechanistic underpinnings of c-Myc/Max dimerization and integrating recent findings on the c-Myc/TERT/NFκB axis, we provide strategic guidance for researchers designing apoptosis, cell cycle arrest, and tumor regression studies. Drawing on real-world workflow insights and peer-reviewed evidence, we differentiate this analysis from standard product pages and offer a forward-looking perspective on the clinical promise and experimental applications of APExBIO’s 10074-G5.

• Demethyleneberberine: Mechanisms in Neurodegenerative Disord

  2026-04-19

  This review paper details how Demethyleneberberine (DMB), a metabolite of berberine, exerts neuroprotective effects by targeting oxidative stress and inflammation pathways central to neurodegeneration. The mechanistic insights highlighted suggest DMB's translational value for research on diseases such as Alzheimer's, Parkinson's, and Huntington's, with protocol-relevant pathway modulation.

• Network Toxicology Reveals Diuron-Induced Renal Injury Mecha

  2026-04-18

  This study integrates network toxicology, transcriptomics, and experimental validation to elucidate the mechanisms underlying Diuron-induced acute kidney injury (AKI). The findings highlight the JAK2/STAT1 signaling pathway as a central mediator of nephrotoxicity, providing a robust framework for toxicological risk assessment and future environmental health studies.

• Stattic and STAT3: Translating Mechanism to Oncology Impact

  2026-04-17

  Explore how selective STAT3 inhibition with Stattic revolutionizes experimental oncology, bridges mechanistic discoveries with translational strategy, and addresses the emerging axis between microbiome dysregulation and cancer therapy resistance. This thought-leadership article integrates the latest evidence, practical protocol guidance, and strategic outlook to empower translational researchers.

• Hoechst 33342: Bis-Benzimidazole Fluorescent Dye for Nuclear

  2026-04-16

  Hoechst 33342 is a bis-benzimidazole fluorescent dye used for selective nuclear staining in live and fixed cells. Its high affinity for DNA minor grooves enables robust chromatin visualization, supporting workflows in cell cycle analysis and apoptosis detection. APExBIO’s A3472 product exemplifies stringent purity and reproducibility standards.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Be

  2026-04-15

  This study introduces a highly selective, cell-active nanomolar inhibitor of insulin-regulated aminopeptidase (IRAP), derived from α-hydroxy-β-amino acid modifications of bestatin. The work demonstrates a novel synthetic strategy enabling both regio- and diastereoselective functionalization, with implications for targeted drug discovery and structure-guided inhibitor design.

• Perospirone Inhibits Kv1.5 Channels in Coronary Smooth Muscl

  2026-04-14

  This study reveals a novel off-target effect of Perospirone (SM-9018 free base), demonstrating its concentration-dependent inhibition of Kv1.5 voltage-gated K+ channels in coronary arterial smooth muscle cells. These findings expand its pharmacological profile beyond classical serotonergic and dopaminergic pathways and underscore potential cardiovascular implications for schizophrenia research.

• 5-hme-dCTP: Transforming DNA Hydroxymethylation Assays in Pl

  2026-04-13

  5-hme-dCTP empowers plant scientists to map and modulate 5-hydroxymethylcytosine with single-base precision, crucial for unraveling drought adaptation and gene regulation. APExBIO’s high-purity modified nucleotide delivers reproducible results in epigenetic DNA modification research, streamlining workflows and overcoming the detection limits that have long hindered plant epigenetics.

• PPP1R3G/PP1γ Regulation of RIPK1: New Insights into Cell Dea

  2026-04-12

  This study uncovers how PPP1R3G recruits PP1γ to dephosphorylate and activate RIPK1, enabling apoptosis and necroptosis. By elucidating the regulatory checkpoints on RIPK1, the work advances understanding of inflammation and cell death, with implications for targeted research in NF-κB signaling and cancer biology.

• 2-APB in ER-Ca2+-Calpain Signaling: Uncovering Autophagy–Apo

  2026-04-12

  Explore how 2-APB (2-aminoethoxydiphenyl borate) uniquely modulates ER-Ca2+-calpain signaling, illuminating the molecular switch between autophagy and apoptosis. This article provides deep practical insights for calcium oscillation studies and oxidative stress research.

• PreScission Protease: Precision HRV 3C Protease for Tag Clea

  2026-04-11

  PreScission Protease (PSP) from APExBIO delivers unmatched specificity for fusion protein tag removal, leveraging HRV 3C protease technology to maximize native protein recovery even at low temperatures. Its performance and reproducibility streamline complex protein purification workflows essential in modern molecular biology and chromatin research.

• Decitabine (5-Aza-2'-deoxycytidine): Protocols for Cancer Ep

  2026-04-11

  Decitabine (5-Aza-2'-deoxycytidine) stands out as a robust DNA methyltransferase inhibitor, enabling reproducible workflows for tumor suppressor gene reactivation in cancer research. This article translates reference study insights and current best practices into actionable protocols and troubleshooting strategies for both hematopoietic and solid tumor models.

• Ferrostatin-1 (Fer-1): Mechanistic Insights and Strategic...

  2026-04-10

  This thought-leadership article dissects the mechanistic, competitive, and translational landscape of Ferrostatin-1 (Fer-1)—a highly selective ferroptosis inhibitor—while offering strategic guidance for researchers deploying this tool in cancer biology, neurodegeneration, and ischemic injury models. Drawing on the latest primary research and established workflows, the article frames Fer-1 not merely as a product but as a pivotal enabler for dissecting iron-dependent oxidative cell death pathways, mapping a visionary outlook for future clinical translation and experimental innovation.

• Necrostatin-1: Precision RIP1 Inhibition for Advanced Nec...

  2026-04-09

  Explore the role of Necrostatin-1, a selective allosteric RIP1 kinase inhibitor, in dissecting necroptosis signaling, inflammation modulation, and innovative disease models. This article uniquely integrates the latest mechanistic insights, preclinical applications, and cross-talk with redox and mitochondrial pathways for next-generation necrotic cell death research.

• Dihydroartemisinin: Antimalarial Agent and mTOR Pathway I...

  2026-04-08

  Dihydroartemisinin is a high-purity antimalarial and mTOR signaling pathway inhibitor widely used in cell proliferation and inflammation research. As supplied by APExBIO, it offers consistent quality and robust evidence of activity in translational disease models.

466 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page